1,125 assets in Non-Small Cell Lung Carcinoma

Therapeutic assets addressing Non-Small Cell Lung Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Idarubicin Non-Small Cell Lung Carcinoma	Second Affiliated Hospital of Guangzhou Medical University	P2	CC (43)
ide892 Non-Small Cell Lung Carcinoma	IDEAYA Biosciences	P1	CC (43)
ik-595 Non-Small Cell Lung Carcinoma	Ikena Oncology	P1	CC (43)
Imm-1-104 Non-Small Cell Lung Carcinoma	Immuneering Corporation	P1/2	CC (43)
Immunoglobulin G1 (134-Cysteine,228-Valine,242-Phenylalanine,243-Glutamic Acid,339-Serine,362-Cysteine,374-Tryptophan), Anti-(Human Cytotoxic T-Lymphocyte-Associated Protein 4) (Human Monoclonal Medi5752 .Gamma.1-Chain), Disulfide With (122-Cysteine,212-Valine) Human Monoclonal Medi5752 .Lambda.-Chain, (234->231')(237->234')(362->354') Tris(Disulfide) With Immunoglobulin G1 (239-Phenylalanine,240-Glutamic Acid,336-Serine,354-Cysteine,371-Serine,373-Alanine,412-Valine) Anti-(Human Programmed Cell Death Protein 1) (Human-Mus Musculus Monoclonal Medi5752 .Gamma.1-Chain) Disulfide With Human-Mus Musculus Monoclonal Medi5752 .Kappa.-Chain Non-Small Cell Lung Carcinoma	AstraZeneca	P1	CC (43)
Ivarmacitinib Non-Small Cell Lung Carcinoma	Chunxia Su	P2	CC (43)
Kb-Gdt-01 Non-Small Cell Lung Carcinoma	Kiromic BioPharma Inc.	P1	CC (43)
Kl-A167 Non-Small Cell Lung Carcinoma	Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.	P2	CC (43)
Lbl-007 Non-Small Cell Lung Carcinoma	BeiGene	P2	CC (43)
lm103 tils Non-Small Cell Lung Carcinoma	Suzhou BlueHorse Therapeutics Co., Ltd.	P2	CC (43)
Modified Vaccinia Virus Ankara Vaccine Expressing P53 Non-Small Cell Lung Carcinoma	City of Hope Medical Center	P1	CC (43)
mov19-bbz car t cells Non-Small Cell Lung Carcinoma	University of Pennsylvania	P1	CC (43)
Mrx-2843 Non-Small Cell Lung Carcinoma	Emory University	P1	CC (43)
mt-4561 Non-Small Cell Lung Carcinoma	Tanabe Pharma America, Inc.	P1/2	CC (43)
Mva-Magea3 Non-Small Cell Lung Carcinoma	Cancer Research UK	P1/2	CC (43)
Mva-Nyeso Non-Small Cell Lung Carcinoma	Cancer Research UK	P1/2	CC (43)
Ningetinib Non-Small Cell Lung Carcinoma	Sunshine Lake Pharma Co., Ltd.	P2	CC (43)
oba01 Non-Small Cell Lung Carcinoma	Lu Shun	P1	CC (43)
Olanzapine Non-Small Cell Lung Carcinoma	Second Affiliated Hospital of Nanchang University	P2	CC (43)
op-3136 Non-Small Cell Lung Carcinoma	Olema Pharmaceuticals, Inc.	P1	CC (43)
Palazestrant Non-Small Cell Lung Carcinoma	Olema Pharmaceuticals, Inc.	P1	CC (43)
Papaverine Non-Small Cell Lung Carcinoma	Ohio State University Comprehensive Cancer Center	P1	CC (43)
Pbf-1129 Non-Small Cell Lung Carcinoma	Dwight Owen	P1	CC (43)
Pd-L1 T-Hank Non-Small Cell Lung Carcinoma	ImmunityBio, Inc.	P2	CC (43)
Pelcitoclax Non-Small Cell Lung Carcinoma	Ascentage Pharma Group Inc.	P1	CC (43)
Pentoxifylline Non-Small Cell Lung Carcinoma	University Health Network, Toronto	P2	CC (43)
pf-07263689 Non-Small Cell Lung Carcinoma	Pfizer	P1	CC (43)
pf-07820435 Non-Small Cell Lung Carcinoma	Pfizer	P1	CC (43)
pf-07826390 Non-Small Cell Lung Carcinoma	Pfizer	P1	CC (43)
pf-08046033 Non-Small Cell Lung Carcinoma	Pfizer	P1	CC (43)
pf-08046037 Non-Small Cell Lung Carcinoma	Pfizer	P1	CC (43)
Phase 1A: Lb-Lr1109 Non-Small Cell Lung Carcinoma	LG Chem	P1	CC (43)
Plx-61639 Non-Small Cell Lung Carcinoma	Plexium, Inc.	P1	CC (43)
Poly-Iclc Non-Small Cell Lung Carcinoma	Olivera Finn	P1/2	CC (43)
Precemtabart Tocentecan Non-Small Cell Lung Carcinoma	EMD Serono Research & Development Institute, Inc.	P1/2	CC (43)
prt7732 Non-Small Cell Lung Carcinoma	Prelude Therapeutics	P1	CC (43)
qls5132 Non-Small Cell Lung Carcinoma	Qilu Pharmaceutical Co., Ltd.	P1/2	CC (43)
Regn5093-M114 Non-Small Cell Lung Carcinoma	Regeneron Pharmaceuticals	P1	CC (43)
Revdofilimab Non-Small Cell Lung Carcinoma	AbbVie	P1	CC (43)
s095018 Non-Small Cell Lung Carcinoma	Servier Bio-Innovation LLC	P1/2	CC (43)
s095024 Non-Small Cell Lung Carcinoma	Servier Bio-Innovation LLC	P1/2	CC (43)
s095029 Non-Small Cell Lung Carcinoma	Servier Bio-Innovation LLC	P1/2	CC (43)
sar445877 Non-Small Cell Lung Carcinoma	M.D. Anderson Cancer Center	P2	CC (43)
Shr-9839 Non-Small Cell Lung Carcinoma	Suzhou Suncadia Biopharmaceuticals Co., Ltd.	P1/2	CC (43)
Shr-A2009 ; Aumolertinib Non-Small Cell Lung Carcinoma	Three Gorges Hospital of Chongqing University	P2	CC (43)
Sleeping Beauty Transposed Pbl Non-Small Cell Lung Carcinoma	National Cancer Institute (NCI)	P2	CC (43)
Sonidegib Non-Small Cell Lung Carcinoma	Mayo Clinic	P1	CC (43)
Stro-004 Non-Small Cell Lung Carcinoma	Sutro Biopharma, Inc.	P1	CC (43)
Stx-241 Non-Small Cell Lung Carcinoma	Pierre Fabre Medicament	P1/2	CC (43)
Sutetinib Non-Small Cell Lung Carcinoma	Teligene US	P2	CC (43)

Showing 601 to 650 of 1,125 assets

PreviousPage 13 of 23Next